| ACEI |
= Angiotensin converting
enzyme inhibitors |
|
LMWH |
= Low-molecular-weight
heparin |
| AMI |
= Acute myocardial
infarction |
|
LVADs |
= Left ventricular assist
devices |
| ANOVA |
= Analysis of
variance |
|
LVEF |
= Left ventricular
ejection fraction |
| ANP |
= Atrial natriuretic
peptide |
|
PCI |
= Percutaneous coronary
intervention |
| ARB |
= Angiotensin receptor
blockers |
|
MSOF |
= Multiple systemic organ
failure |
| ASCEND-HF |
= Acute Study of Clinical
Effectiveness of Nesiritide |
|
NT-proBNP |
= N-terminal brain
natriuretic peptide |
| |
and Decompensated Heart
Failure |
|
PCWP |
= Pulmonary capillary
wedge pressure |
| BNP |
= B type natriuretic
peptide |
|
RAP |
= Right atrial
pressure |
| CABG |
= Coronary artery bypass
graft surgery |
|
rhBNP |
= Recombinant human brain
natriuretic peptide |
| cGMP |
= Cyclic guanosine
monophosphate |
|
SBP |
= Systolic blood
pressure |
| CI |
= Cardiac index |
|
SOAP |
= Sepsis occurrence in
acutely ill patients |
| cTnI |
= Cardiac troponin I |
|
SPSS |
= Statistical Package for
the Social Sciences |
| ECG |
= Eletrocardiograma |
|
STEMI |
= ST segment elevation
myocardial infarction |
| eGFR |
= Estimate glomerular
filtration rate |
|
VMAC |
= Vasodilation in the
Management of Acute |
| FDA |
= U. S. Food and Drug
Administration |
|
|
Congestive Heart
Failure |
| IABP |
= Intra-aortic balloon
pump |
|
|
|